Functional intermuscular reduction in spasticity for people with multiple sclerosis.

Bobbette J MillerThubi Ha KolobeRebecca D LarsonBrian A PribbleGabriel Pardo Shirley A James

Published in: Multiple sclerosis journal - experimental, translational and clinical (2022)

Results of this novel protocol suggest this intervention combination has the potential to decrease spasticity, and improve gait speed and endurance in individuals with MS. Observed changes in mobility occurred without accompanying increases in fatigue.

Keyphrases

multiple sclerosis
cerebral palsy
botulinum toxin
spinal cord injury
randomized controlled trial
upper limb
children with cerebral palsy
skeletal muscle
white matter
high intensity
mass spectrometry
resistance training
sleep quality
ms ms
human health
risk assessment
physical activity
body composition